Article info
PDFExtended report
Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis
- Correspondence to:
Professor J Braun
Rheumazentrum Ruhrgebiet, Landgrafenstr 15, 44652 Herne, Germany; J.BraunRheumazentrum-Ruhrgebiet.de
Citation
Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis
Publication history
- Accepted June 20, 2004
- First published September 23, 2004.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by Annals of the Rheumatic Diseases